LAS VEGAS – The latest topical treatments “are going to change the way we treat onychomycosis,” Dr. David Pariser said at the Skin Disease Education Foundation’s annual Las Vegas dermatology seminar.
In an interview at the meeting, Dr. Pariser of Eastern Virginia Medical School, Norfolk, explained how the newly approved topical onychomycosis drugs work and shared some treatment strategies. Do they work even when patients are wearing nail polish? Tune in and find out.
SDEF and this news organization are owned by Frontline Medical Communications. Dr. Pariser has served as an investigator and consultant for Valeant and an investigator for Anacor.